BRAVA CRT-D, BRAVA QUAD CRT-D, CONCERTO II CRT-D, CONSULTA CRT-D, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D,
FDA premarket approval P010031/S475 · decided 2014-12-19
Approval details
- PMA number
- P010031
- Supplement
- S475
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA CRT-D, BRAVA QUAD CRT-D, CONCERTO II CRT-D, CONSULTA CRT-D, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D,
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-12-05
- Decision date
- 2014-12-19
- Days to decision
- 14 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- NEW SUPPLIER FOR GOLD PREFORM COMPONENTS THAT ARE USED AS BRAZING PREFORMS IN THE MANUFACTURING OF FEEDTHROUGHS FOR THE DEVICES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.